FindTrial
Sign In

Effect of introducing low-concentration bupivacaine into the abdominal cavity of participants for post-operative pain relief outcome after laparoscopic hysterectomy.

Effect of intra-peritoneal instillation of low-concentration bupivacaine for post-operative analgesia after laparoscopic hysterectomy. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/091012
Enrollment
52
Registered
2025-07-16
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N958- Other specified menopausal and perimenopausal disorders

Interventions

Intervention1: Intra-peritoneal instillation of low-concentration bupivacaine over 10 minutes: At the end of laparoscopic hysterectomy Intra-peritoneal instillation of inj.Bupivacaine 0.1% 100ml at th

Sponsors

Government of Gujarat
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade I and II, Elective surgeries

Exclusion criteria

Exclusion criteria: Hypersensitivity to local anaesthetics, History of any previous surgery

Design outcomes

Primary

MeasureTime frame
To compare duration of analgesiaTimepoint: Postoperative 24 hours—

Secondary

MeasureTime frame
To monitor and compare the incidence of adverse effectsTimepoint: Postoperative 24 hours;To assess postoperative hemodynamic parameters in both groupsTimepoint: Postoperative 24 hours—

Countries

India

Contacts

Public ContactDr Nilesh Solanki

B.J.Medical College and Civil Hospital

nmscbaps@gmail.com9998991716

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026